San Diego, CA, United States of America

Anders Mikal Eliasen

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Scripps Research Institute. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anders Mikal Eliasen. Retrieved from https://idiyas.com/inventor/anders-mikal-eliasen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Inventor Spotlight: Anders Mikal Eliasen

Introduction: Meet Anders Mikal Eliasen, a brilliant inventor based in San Diego, CA, with a passion for combating malaria through innovative solutions.

Latest Patents: Anders Mikal Eliasen has recently patented two groundbreaking inventions - "Antimalarial compositions and uses thereof." These compounds and compositions are designed to treat and prevent malaria effectively, showcasing his dedication to improving global health.

Career Highlights: Currently affiliated with The Scripps Research Institute, Anders Mikal Eliasen has established himself as a key player in the field of pharmaceutical research. His expertise and commitment to developing life-saving treatments have earned him recognition among peers and industry experts.

Collaborations: Working alongside talented individuals like Wil Joseph Andahazy and Arnab Kumar Chatterjee, Anders Mikal Eliasen thrives in collaborative environments where ideas flourish, leading to impactful innovations in the fight against infectious diseases.

Conclusion: In conclusion, Anders Mikal Eliasen's contributions to the healthcare sector, particularly in the realm of antimalarial treatments, are invaluable. His relentless pursuit of novel solutions underscores his pivotal role in shaping the future of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…